MannKind Corp. (MNKD)
2.77
+0.03
(+1.09%)
USD |
NASDAQ |
Apr 15, 16:00
2.76
-0.01
(-0.36%)
After-Hours: 18:53
MannKind Research and Development Expense (Annual) : 66.35M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| United Therapeutics Corp. | 550.00M |
| Amicus Therapeutics, Inc. | 135.84M |
| Keros Therapeutics, Inc. | 127.09M |
| BioMarin Pharmaceutical, Inc. | 700.97M |
| Ionis Pharmaceuticals, Inc. | 913.18M |